Nova Wealth Management’s ResMed RMD Stock Holding History

Nova Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7	Closed	-$1.76K	–	627
2025 Q4	$1.76K	Hold	7	–	–	﹤0.01%	518
2025 Q3	$2K	Sell	7 -5	-42%	-$1.37K	﹤0.01%	510
2025 Q2	$3.01K	Buy	+12	New	+$2.86K	﹤0.01%	506

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nova Wealth Management's RMD Position: Q1 2026 in Review

Nova Wealth Management sold out of ResMed (RMD) in Q1 2026, closing a stake of 7 shares — an estimated $1.76K sold.

Nova Wealth Management first reported a position in RMD in Q2 2025 and held it in 3 quarters. The position peaked at $3.01K in Q2 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Nova Wealth Management reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Nova Wealth Management sold 7 ResMed shares in Q1 2026, an estimated $1.76K.
Nova Wealth Management first reported a position in ResMed in Q2 2025 and held it in 3 quarters.
Nova Wealth Management's ResMed position peaked at $3.01K in Q2 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Nova Wealth Management's 13F filing for Q1 2026, filed 14 Apr 2026.